SynthesisPacing and clinical electrophysiology : PACE2022
Catheter ablation for papillary muscle arrhythmias: A systematic review.
Synthesis in Pacing and clinical electrophysiology : PACE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Catheter ablation for papillary muscle arrhythmias: A systematic review.Pacing and clinical electrophysiology : PACE · 2022Pooled it
- Iatrogenic ventricular septal defect following papillary muscle premature ventricular contraction ablation: a case report.European heart journal. Case reports · 2026Article
- Key role of intracardiac echocardiography in catheter ablation of anterolateral papillary muscles.The international journal of cardiovascular imaging · 2026Article
- Anatomic complexities of the human right ventricle: Considerations for clinical practice in the electrophysiology laboratory.Heart rhythm O2 · 2026Review
- Diagnostic accuracy of ChatGPT for 12-lead ECG-based localisation of ventricular ectopic foci prior to catheter ablation.Frontiers in medicine · 2025Article
- Bipolar radiofrequency catheter ablation of incessant ventricular tachycardia originating from anterolateral papillary muscle.HeartRhythm case reports · 2024Article
- Preclinical Study of Pulsed Field Ablation of Difficult Ventricular Targets: Intracavitary Mobile Structures, Interventricular Septum, and Left Ventricular Free Wall.Circulation. Arrhythmia and electrophysiology · 2024Article
- Robotics, remote medicine, AI: Oh my!HeartRhythm case reports · 2024Article
- Article
- Feasibility and safety of reprocessing of intracardiac echocardiography catheters for electrophysiology procedures - a large single center experience.Cardiovascular ultrasound · 2023Article
- Radiofrequency ablation of premature ventricular contractions guided by robotic magnetic navigation combined with pattern matching filter.Clinical cardiology · 2023Article
- Combination of Intracardiac Echocardiography and Contact Force Sensing for Left Ventricular Papillary Muscle Arrhythmias.Journal of clinical medicine · 2023Article
- Catheter ablation of pediatric ventricular arrhythmias: A work in progress.Indian pacing and electrophysiology journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCatheter ablation of papillary muscle ventricular arrhythmias (PM-VAs) has been associated with unsatisfactory results. Features that may affect acute and long-term procedural outcomes are not well established.
objectiveTo systematically review the available data in the literature assessing efficacy and safety of PM-VAs catheter ablation.
methodsAn online search of PubMed, Cochrane Registry, Web of Science, Scopus and EMBASE libraries (from inception to March 1, 2021) was performed, in addition to manual screening. Twenty-one observational noncontrolled case-series were considered eligible for the systematic review, including 536 patients.
resultsPostero-medial PM harbored 60.8% of PM-VAs, while antero-lateral PM and right ventricular PMs 34.9% and 4.3% of cases, respectively. The mean acute success rate of the index ablation procedure was 88.1% (95% CI 82.8% to 91.9%, p < .001, I
conclusionsCatheter ablation is an effective and safe strategy for PM-VAs, with an acute success rate of 88.1%, a long-term success rate of 69.2%, with a relatively low procedural complication rate. The use of ICE, irrigated catheters and catheters with CFS capability was associated with higher rates of arrhythmia-freedom at long-term follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.